Johnson & Johnson Exec Sells Stock Options Worth Over $3.9 Million
Jennifer Taubert, Executive Vice President and Worldwide Chairman of Innovative Medicine at Johnson & Johnson (NYSE:JNJ), made significant stock transactions on August 17, 2026.
Taubert exercised employee stock options to acquire 15,000 shares of common stock with an exercise price of $115.67 per share, totaling $1,735,050.
She then sold the same number of shares at a weighted average price of $263.36, generating approximately $3.95 million from the sale.